Literature DB >> 18922591

The presence of abdominal obesity is associated with changes in vascular function independently of other cardiovascular risk factors.

Christian F Rueda-Clausen1, Vicente Lahera, Jaime Calderón, Isabel Cristina Bolivar, Victor R Castillo, Melquisedec Gutiérrez, Marisol Carreño, Maria del Pilar Oubiña, Victoria Cachofeiro, Patricio López-Jaramillo.   

Abstract

BACKGROUND: Because of the strong association between abdominal obesity (AO) and other cardiovascular risk factors, it has been difficult to determine which changes in vascular function are directly related to this condition. Our objective was to evaluate the changes in ex-vivo vascular reactivity, circulating levels of adipokines and inflammatory markers associated with the presence of AO in subjects who underwent coronary artery bypass graft (CABG) controlling by the presence of other cardiovascular risk factors.
METHODS: Subjects scheduled for a CABG with (n=17) and without (n=17) AO (defined as a waist circumference > or =90 cm for male or > or =80 cm for female) whom were matched by several cardiovascular risk factors, were included in the study. Lipid profile and plasma levels of glucose, insulin, leptin, adiponectin and inflammatory markers were measured. Internal mammary artery segments were used for ex-vivo vascular reactivity experiments and morphometry.
RESULTS: Leptin concentrations were higher and adiponectin concentrations were lower in subjects with AO. No differences were observed in other biochemical or clinical parameters between the groups. No correlation between waist circumference, HOMA index and inflammatory markers were observed. Endothelium-dependent relaxation to acetylcholine was lower, and contractile responses to angiotensin-II were higher in subjects with AO. These changes were not related to differences in vascular morphometry.
CONCLUSION: In subjects with severe coronary disease, the presence of AO was associated with leptin/adiponectin imbalance, decreased endothelium-dependent relaxation and an enhanced response to angiotensin-II. These changes occurred independently of other cardiovascular risk factors including insulin resistance and levels of inflammatory markers. Copyright 2008 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18922591     DOI: 10.1016/j.ijcard.2008.09.005

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  13 in total

1.  Rosuvastatin restored adrenergic and nitrergic function in mesenteric arteries from obese rats.

Authors:  Javier Blanco-Rivero; Natalia de las Heras; Beatriz Martín-Fernández; Victoria Cachofeiro; Vicente Lahera; Gloria Balfagón
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

Review 2.  Is the present cut-point to define type 2 diabetes appropriate in Latin-Americans?

Authors:  Patricio López-Jaramillo; Carlos Velandia-Carrillo; Diego Gómez-Arbeláez; Martin Aldana-Campos
Journal:  World J Diabetes       Date:  2014-12-15

3.  Sex-specific association of anthropometric measures of body composition with arterial stiffness in a healthy population.

Authors:  Danijela Budimir; Ana Jeroncic; Grgo Gunjaca; Igor Rudan; Ozren Polasek; Mladen Boban
Journal:  Med Sci Monit       Date:  2012-02

4.  Maternal undernutrition and cardiometabolic disease: a Latin American perspective.

Authors:  Patricio Lopez-Jaramillo; Diego Gomez-Arbelaez; Aristides Sotomayor-Rubio; Daniel Mantilla-Garcia; Jose Lopez-Lopez
Journal:  BMC Med       Date:  2015-03-02       Impact factor: 8.775

5.  Association of intracellular lipid accumulation in subcutaneous adipocyte precursors and plasma adipokines in bariatric surgery candidates.

Authors:  Ioana Hristov; Veronica Mocanu; Florin Zugun-Eloae; Luminita Labusca; Iustina Cretu-Silivestru; Teodor Oboroceanu; Crina Tiron; Adrian Tiron; Alexandrina Burlacu; Alin Constantin Pinzariu; Ioana Armasu; Radu Mircea Neagoe; Adrian Covic; Viorel Scripcariu; Daniel Vasile Timofte
Journal:  Lipids Health Dis       Date:  2019-06-13       Impact factor: 3.876

6.  Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus: A population-based study.

Authors:  Wei Liu; Xianghai Zhou; Yufeng Li; Simin Zhang; Xiaoling Cai; Rui Zhang; Siqian Gong; Xueyao Han; Linong Ji
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.889

7.  Serum adipokines/related inflammatory factors and ratios as predictors of infrapatellar fat pad volume in osteoarthritis: Applying comprehensive machine learning approaches.

Authors:  Hossein Bonakdari; Ginette Tardif; François Abram; Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  Sci Rep       Date:  2020-06-19       Impact factor: 4.379

8.  Aged garlic extract improves adiponectin levels in subjects with metabolic syndrome: a double-blind, placebo-controlled, randomized, crossover study.

Authors:  Diego Gómez-Arbeláez; Vicente Lahera; Pilar Oubiña; Maria Valero-Muñoz; Natalia de Las Heras; Yudy Rodríguez; Ronald Gerardo García; Paul Anthony Camacho; Patricio López-Jaramillo
Journal:  Mediators Inflamm       Date:  2013-02-28       Impact factor: 4.711

9.  Inflammation and hypertension: are there regional differences?

Authors:  Patricio López-Jaramillo; Carlos Velandia-Carrillo; Julie Alvarez-Camacho; Daniel Dylan Cohen; Tatiana Sánchez-Solano; Gabriela Castillo-López
Journal:  Int J Hypertens       Date:  2013-03-21       Impact factor: 2.420

Review 10.  The Link between Fetal Programming, Inflammation, Muscular Strength, and Blood Pressure.

Authors:  Jose Lopez-Lopez; Patricio Lopez-Jaramillo; Paul A Camacho; Diego Gomez-Arbelaez; Daniel D Cohen
Journal:  Mediators Inflamm       Date:  2015-09-27       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.